SS Innovations International, Inc. (SSII)'s SSi Mantra System Sees 130% Installation Growth, Pioneers Cardiac Telesurgery

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. SS Innovations International, Inc. is one of them.

SS Innovations International, Inc. (NASDAQ:SSII) is advancing affordable surgical robotics with its flagship SSi Mantra system, offering a cost-efficient alternative to established platforms like Intuitive Surgical’s da Vinci. Approved in seven countries, including India, Indonesia, and the Philippines, the company is pursuing regulatory approval in the U.S. and Europe to expand its global footprint.

In September 2025, Naveen Kumar Amar was appointed Chief Financial Officer, bringing extensive international finance experience as SSII ramps up sales and prepares submissions for a U.S. FDA 510(k) application by October and CE mark certification in Europe in the first half of 2026.

Financially, SS Innovations International, Inc. (NASDAQ:SSII) posted strong growth in Q2 2025, with revenue rising 121.8% to $10 million and gross profit more than tripling year-over-year. Installations of the SSi Mantra system surged 130% year-over-year, bringing the total installed base to 105 systems performing 4,657 surgeries as of June 30, 2025. Among its achievements, the firm performed the world’s first intercontinental robotic cardiac telesurgery in July 2025, highlighting its technological capabilities.

While we acknowledge the potential of SSII as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.